Cargando…

Is there an inherent limit to acute migraine treatment efficacy?

Detalles Bibliográficos
Autores principales: Bigal, Marcelo E., Ho, Tony W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Milan 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3476204/
https://www.ncbi.nlm.nih.gov/pubmed/19820895
http://dx.doi.org/10.1007/s10194-009-0162-y
_version_ 1782247073245036544
author Bigal, Marcelo E.
Ho, Tony W.
author_facet Bigal, Marcelo E.
Ho, Tony W.
author_sort Bigal, Marcelo E.
collection PubMed
description
format Online
Article
Text
id pubmed-3476204
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher Springer Milan
record_format MEDLINE/PubMed
spelling pubmed-34762042012-11-29 Is there an inherent limit to acute migraine treatment efficacy? Bigal, Marcelo E. Ho, Tony W. J Headache Pain Commentary Springer Milan 2009-10-10 2009-12 /pmc/articles/PMC3476204/ /pubmed/19820895 http://dx.doi.org/10.1007/s10194-009-0162-y Text en © Springer-Verlag 2009
spellingShingle Commentary
Bigal, Marcelo E.
Ho, Tony W.
Is there an inherent limit to acute migraine treatment efficacy?
title Is there an inherent limit to acute migraine treatment efficacy?
title_full Is there an inherent limit to acute migraine treatment efficacy?
title_fullStr Is there an inherent limit to acute migraine treatment efficacy?
title_full_unstemmed Is there an inherent limit to acute migraine treatment efficacy?
title_short Is there an inherent limit to acute migraine treatment efficacy?
title_sort is there an inherent limit to acute migraine treatment efficacy?
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3476204/
https://www.ncbi.nlm.nih.gov/pubmed/19820895
http://dx.doi.org/10.1007/s10194-009-0162-y
work_keys_str_mv AT bigalmarceloe isthereaninherentlimittoacutemigrainetreatmentefficacy
AT hotonyw isthereaninherentlimittoacutemigrainetreatmentefficacy